TREM2 and Alzheimer disease: We investigated whether these networks and their ‘hubs’ were altered in brain tissue from AD donors compared to control donors, and in brain tissue from AD carriers of rare TREM2 risk variants [AD(TREM2+)] compared to controls and AD donors with no TREM2 risk variants [AD(TREM2−)].